STAT3 and hepatocellular carcinoma: To sum up, TPL can effectively inhibit hepatoma cell proliferation and promote cancer cell apoptosis, and exert its anti-hepatoma effect, and inhibiting JAK1/STAT3 signaling may activate apoptosis-related pathways.